Home › Funds › BRADLEY FOSTER & SARGENT INC/CT › APH

BRADLEY FOSTER & SARGENT INC/CT position in APH

AMPHENOL CORP · Technology

BRADLEY FOSTER & SARGENT INC/CT reported holding 1,710,134 shares of APH (AMPHENOL CORP) in its Q3 2026 13F filing — a position valued at US$144.2M, representing 2.06% of its reported portfolio and ranking #9 among its reported holdings. BRADLEY FOSTER & SARGENT INC/CT has disclosed APH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.71M sh
Reported value held$144.16M
Portfolio Weight2.06%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How BRADLEY FOSTER & SARGENT INC/CT's APH position evolved

BRADLEY FOSTER & SARGENT INC/CT first disclosed a stake in APH in Q3 2023 at 475,606 shares (US$40.4M). The position peaked in Q2 2026 at 898,902 shares, worth US$158.5M. Across 13 filings, BRADLEY FOSTER & SARGENT INC/CT increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,710,134 shares valued at US$144.2M — an increase of 811,232 shares quarter over quarter.. Notable position changes include a 98% increase in Q2 2024 (shares fell 3% over the following quarter), a 90% increase in Q3 2026 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 475.61K $40.40M New
Q4 2023 510.71K $50.63M Add
Q1 2024 511.58K $59.01M Hold
Q2 2024 1.01M $68.23M Add
Q3 2024 1.03M $67.27M Add
Q4 2024 1.04M $72.56M Add
Q1 2025 1.04M $68.01M Reduce
Q2 2025 1.03M $101.78M Reduce
Q3 2025 1.02M $126.02M Reduce
Q4 2025 1.01M $136.18M Reduce
Q1 2026 886.12K $111.96M Reduce
Q2 2026 898.90K $158.49M Add
Q3 2026 1.71M $144.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About APH and 13F data

APH (AMPHENOL CORP) is a Technology company. 45 other funds we track also report a position in APH — the largest reported positions include Fidelity Management & Research (FMR) (US$10.58B), Capital International Investors (US$7.30B), VANGUARD PORTFOLIO MANAGEMENT LLC (US$6.07B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APH

All APH fund holders →

FAQ

How long has BRADLEY FOSTER & SARGENT INC/CT held APH?

BRADLEY FOSTER & SARGENT INC/CT has disclosed APH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BRADLEY FOSTER & SARGENT INC/CT's current position in APH?

As of Q3 2026, BRADLEY FOSTER & SARGENT INC/CT holds 1.71M shares of APH (AMPHENOL CORP), valued at $144.16M, representing 2.06% of its reported portfolio and ranking #9.

Has BRADLEY FOSTER & SARGENT INC/CT been buying or selling APH?

In the latest 13F filing (Q3 2026), BRADLEY FOSTER & SARGENT INC/CT increased its position in APH. The position peaked in Q2 2026 at 898.90K shares.

Which other funds hold APH?

Other major institutional holders of APH include Fidelity Management & Research (FMR), Capital International Investors, VANGUARD PORTFOLIO MANAGEMENT LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.